[Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review].

Relations entre doses dans les structures anatomiques et dysfonction érectile après radiothérapie pour un cancer de la prostate : revue systématique de la littérature.
Cancer de prostate Dysfonction érectile Erectile dysfunction Prostate cancer Radiotherapy Radiothérapie Sexual toxicity Toxicité sexuelle

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 11 07 2023
accepted: 12 07 2023
medline: 12 9 2023
pubmed: 19 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

During prostatic radiotherapy, damage to several anatomical structures could be the cause of erectile dysfunction: corpora cavernosa, internal pudendal arteries, penile bulb, and neurovascular bundles. Numerous studies have analysed the correlations between the dose received by these structures and erectile function. The objective of this article is to make a systematic review on current knowledge. A systematic review was performed in the Medline database using the search engine PubMed. Keywords for the search included: erectile dysfunction, penile bulb, corpora cavernosa, cavernosum, neurovascular bundles, radiation therapy, cancer, prostate cancer. The selected articles must study a correlation between erectile dysfunction and the dose received by anatomical structures. A total of 152 articles were identified. Of these 152 articles, 45 fulfilled the defined selection criteria. For corpora cavernosa, seven studies were identified, only two studies demonstrated a significant correlation between the dose received by corpora cavernosa and the occurrence of erectile dysfunction. For penile bulb, only 15 of 23 studies showed a correlation. A mean dose on the penile bulb greater than 20Gy was found to be predictive of erectile dysfunction. None of the eight trials concerning neurovascular bundles succeeded to show a correlation between dose and erectile dysfunction. Only one study evaluated the relationship between the dose received by internal pudendal arteries and erectile dysfunction but was found to be negative. However, vessels-sparing studies showed good results on erectile function preservation without compromising the target volume. We currently have little data to show a correlation between erectile dysfunction and sexual structures. It would be necessary to have additional prospective studies evaluating the impact of an optimization on these sexual structures on erectile dysfunction.

Identifiants

pubmed: 37596125
pii: S1278-3218(23)00152-X
doi: 10.1016/j.canrad.2023.07.010
pii:
doi:

Types de publication

Systematic Review English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

548-561

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Auteurs

A Ailloud (A)

Département de radiothérapie-oncologie, hôpital Lyon-Sud, Pierre-Bénite, France.

C Udrescu (C)

Département de radiothérapie-oncologie, hôpital Lyon-Sud, Pierre-Bénite, France; Université Claude-Bernard Lyon 1, Pierre-Bénite, France.

S Horn (S)

Département de radiothérapie-oncologie, hôpital Lyon-Sud, Pierre-Bénite, France.

C Enachescu (C)

Département de radiothérapie-oncologie, hôpital Lyon-Sud, Pierre-Bénite, France.

G Créhange (G)

Département de radiothérapie-oncologie, institut Curie, Paris, France; Université PSL, université Paris-Saclay, U1288, Inserm Lito, Orsay, France.

P Sargos (P)

Département de radiothérapie-oncologie, institut Bergonié, Bordeaux, France.

S Supiot (S)

Département de radiothérapie-oncologie, institut de cancérologie de l'Ouest, centre René-Gauducheau, Saint-Herblain, France.

T Zilli (T)

Département de radiothérapie-oncologie, hôpitaux universitaires de Genève, Genève, Suisse; Université de médecine de Genève, Genève, Suisse.

A Lapierre (A)

Département de radiothérapie-oncologie, hôpital Lyon-Sud, Pierre-Bénite, France; Université Claude-Bernard Lyon 1, Pierre-Bénite, France.

O Chapet (O)

Département de radiothérapie-oncologie, hôpital Lyon-Sud, Pierre-Bénite, France; Université Claude-Bernard Lyon 1, Pierre-Bénite, France. Electronic address: olivier.chapet@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH